Who We Are
340B Health represents public and private nonprofit hospitals and health systems that participate in the 340B drug discount program.Learn more about us
Meet Mikayla, Our Newest Patient Face of 340BClick here to watch
Visit The Exchange today to connect with over 9,000 of your 340B colleagues on the topics that matter most.Click here to post
July 9, 2019– The 340B drug pricing program may discourage drug manufacturers from raising prices and instead may have the effect of reducing list prices for certain drugs. That’s according to a new study published in the Journal of the American Medical Association (JAMA).